Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GLAUKOS Corp Director's Dealing 2015

Jun 24, 2015

31074_dirs_2015-06-24_44e972b1-6b5d-4337-b849-43c954fbfe7c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: GLAUKOS Corp (GKOS)
CIK: 0001192448
Period of Report: 2015-06-24

Reporting Person: LINK WILLIAM J PHD (Director, 10% Owner)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Series A Convertible Preferred Stock $ Common Stock (552000) Indirect
Series A Convertible Preferred Stock $ Common Stock (12000) Indirect
Series A Convertible Preferred Stock $ Common Stock (25200) Indirect
Series A Convertible Preferred Stock $ Common Stock (10800) Indirect
Series B Convertible Preferred Stock $ Common Stock (851852) Indirect
Series B Convertible Preferred Stock $ Common Stock (18518) Indirect
Series B Convertible Preferred Stock $ Common Stock (38888) Indirect
Series B Convertible Preferred Stock $ Common Stock (16666) Indirect
Series C Convertible Preferred Stock $ Common Stock (479714) Indirect
Series C Convertible Preferred Stock $ Common Stock (10428) Indirect
Series C Convertible Preferred Stock $ Common Stock (21900) Indirect
Series C Convertible Preferred Stock $ Common Stock (9386) Indirect
Series D Convertible Preferred Stock $ Common Stock (548464) Indirect
Series D Convertible Preferred Stock $ Common Stock (11805) Indirect
Series D Convertible Preferred Stock $ Common Stock (25226) Indirect
Series D Convertible Preferred Stock $ Common Stock (10791) Indirect
Series E Convertible Preferred Stock $ Common Stock (163592) Indirect
Series E Convertible Preferred Stock $ Common Stock (3420) Indirect
Series E Convertible Preferred Stock $ Common Stock (7684) Indirect
Series E Convertible Preferred Stock $ Common Stock (3271) Indirect
Series F Convertible Preferred Stock $ Common Stock (273337) Indirect
Series F Convertible Preferred Stock $ Common Stock (5715) Indirect
Series F Convertible Preferred Stock $ Common Stock (12840) Indirect
Series F Convertible Preferred Stock $ Common Stock (5465) Indirect
Series D Convertible Preferred Stock Warrant (right to buy) $ Common Stock (27612) Indirect
Series D Convertible Preferred Stock Warrant (right to buy) $ Common Stock (577) Indirect
Series D Convertible Preferred Stock Warrant (right to buy) $ Common Stock (1296) Indirect
Series D Convertible Preferred Stock Warrant (right to buy) $ Common Stock (552) Indirect
Stock Option (right to buy) $7.275 2024-07-10 Common Stock (10000) Direct

Footnotes

F1: The shares of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock, Series D Convertible Preferred Stock, Series E Convertible Preferred Stock and Series F Convertible Preferred Stock shall automatically convert into shares of common stock on a 1:1 basis immediately prior to the consummation of Issuer's initial public offering ("IPO") and have no expiration date.

F2: The warrants to acquire Series D Convertible Preferred Stock shall automatically net exercise immediately prior to consummation of the IPO at the IPO price per share and the shares of Series D Convertible Preferred Stock received thereupon shall automatically convert into shares of common stock as described in footnote (1).

F3: Granted July 10, 2014 pursuant to the Issuer's 2011 Stock Plan. Vests annually over a three-year period such that it is vested in full on the three-year anniversary of the grant date.

F4: Versant Ventures I, LLC, a Delaware limited liability company (''VV I'') serves as the sole general partner of Versant Venture Capital I, L.P., a Delaware limited partnership ("VVC I"); Versant Affiliates Fund I-A, L.P., a Delaware limited partnership (''VAF I-A''), Versant Affiliates Fund I-B, L.P., a Delaware limited partnership (''VAF I-B''); and Versant Side Fund I, L.P., a Delaware limited partnership (''VSF I''). VV I owns no shares directly. Dr. Link is a director and/or member of VV I and shares voting and dispositive power over the shares held by VVC I, VAF I-A, VAF 1-B and VSF I; however, he disclaims beneficial ownership of the shares held by such entities except to the extent of his pecuniary interests therein.